Broad Targeting Specificity during Bacterial Type III CRISPR-Cas Immunity Constrains Viral Escape.

CRISPR loci are a cluster of repeats separated by short "spacer" sequences derived from prokaryotic viruses and plasmids that determine the targets of the host's CRISPR-Cas immune response against its invaders. For type I and II CRISPR-Cas systems, single-nucleotide mutations in the seed or protospacer adjacent motif (PAM) of the target sequence cause immune failure and allow viral escape. This is overcome by the acquisition of multiple spacers that target the same invader. Here we show that targeting by the Staphylococcus epidermidis type III-A CRISPR-Cas system does not require PAM or seed sequences, and thus prevents viral escape via single-nucleotide substitutions. Instead, viral escapers can only arise through complete target deletion. Our work shows that, as opposed to type I and II systems, the relaxed specificity of type III CRISPR-Cas targeting provides robust immune responses that can lead to viral extinction with a single spacer targeting an essential phage sequence.

[1]  Jos Boekhorst,et al.  Degenerate target sites mediate rapid primed CRISPR adaptation , 2014, Proceedings of the National Academy of Sciences.

[2]  Stan J. J. Brouns,et al.  Cas3-Derived Target DNA Degradation Fragments Fuel Primed CRISPR Adaptation. , 2016, Molecular cell.

[3]  D. G. Gibson,et al.  Enzymatic assembly of DNA molecules up to several hundred kilobases , 2009, Nature Methods.

[4]  R. Barrangou,et al.  Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria , 2012, Proceedings of the National Academy of Sciences.

[5]  Luciano A. Marraffini,et al.  Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting , 2014, Nature.

[6]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[7]  M. Caparon,et al.  Mry, a trans-acting positive regulator of the M protein gene of Streptococcus pyogenes with similarity to the receptor proteins of two-component regulatory systems , 1991, Journal of bacteriology.

[8]  Konstantin Severinov,et al.  Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system , 2012, Nature Communications.

[9]  Vincent A. Fischetti,et al.  Sorting of protein a to the staphylococcal cell wall , 1992, Cell.

[10]  Jing Zhang,et al.  CRISPR-mediated targeted mRNA degradation in the archaeon Sulfolobus solfataricus , 2014, Nucleic acids research.

[11]  Albert J R Heck,et al.  RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions , 2011, Proceedings of the National Academy of Sciences.

[12]  Eli J. Fine,et al.  DNA targeting specificity of RNA-guided Cas9 nucleases , 2013, Nature Biotechnology.

[13]  Jennifer A. Doudna,et al.  Structures of the CRISPR-Cmr complex reveal mode of RNA target positioning , 2015, Science.

[14]  A. Buckling,et al.  The diversity-generating benefits of a prokaryotic adaptive immune system , 2016, Nature.

[15]  Wenyan Jiang,et al.  Impact of Different Target Sequences on Type III CRISPR-Cas Immunity , 2016, Journal of bacteriology.

[16]  Roger W. Hendrix,et al.  Phage Genomics Small Is Beautiful , 2002, Cell.

[17]  Feng Zhang,et al.  CRISPR-assisted editing of bacterial genomes , 2013, Nature Biotechnology.

[18]  L. Marraffini,et al.  CRISPR Interference Limits Horizontal Gene Transfer in Staphylococci by Targeting DNA , 2008, Science.

[19]  M. F. White,et al.  A type III-B CRISPR-Cas effector complex mediating massive target DNA destruction , 2016, Nucleic acids research.

[20]  M. O'Reilly,et al.  The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage , 1983, Nature.

[21]  J. Doudna,et al.  Surveillance and Processing of Foreign DNA by the Escherichia coli CRISPR-Cas System , 2015, Cell.

[22]  Joshua R. Elmore,et al.  Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR–Cas system , 2016, Genes & development.

[23]  Jennifer A. Doudna,et al.  DNA interrogation by the CRISPR RNA-guided endonuclease Cas9 , 2014, Nature.

[24]  Scott Bailey,et al.  RNA-activated DNA cleavage by the Type III-B CRISPR-Cas effector complex. , 2016, Genes & development.

[25]  Dipali G. Sashital,et al.  CRISPR interference and priming varies with individual spacer sequences , 2015, Nucleic acids research.

[26]  P. Bonnen,et al.  First Complete Genome Sequence of Two Staphylococcus epidermidis Bacteriophages , 2006, Journal of bacteriology.

[27]  Philippe Horvath,et al.  Phage Response to CRISPR-Encoded Resistance in Streptococcus thermophilus , 2007, Journal of bacteriology.

[28]  G. Mohr,et al.  Direct CRISPR spacer acquisition from RNA by a natural reverse transcriptase–Cas1 fusion protein , 2016, Science.

[29]  Bruce R. Levin,et al.  Dealing with the Evolutionary Downside of CRISPR Immunity: Bacteria and Beneficial Plasmids , 2013, PLoS genetics.

[30]  J. García-Martínez,et al.  Short motif sequences determine the targets of the prokaryotic CRISPR defence system. , 2009, Microbiology.

[31]  Erik J. Sontheimer,et al.  Self vs. non-self discrimination during CRISPR RNA-directed immunity , 2009, Nature.

[32]  Wenyan Jiang,et al.  A Ruler Protein in a Complex for Antiviral Defense Determines the Length of Small Interfering CRISPR RNAs , 2013, The Journal of Biological Chemistry.

[33]  Česlovas Venclovas,et al.  Spatiotemporal Control of Type III-A CRISPR-Cas Immunity: Coupling DNA Degradation with the Target RNA Recognition. , 2016, Molecular cell.

[34]  Albert J R Heck,et al.  RNA targeting by the type III-A CRISPR-Cas Csm complex of Thermus thermophilus. , 2014, Molecular cell.

[35]  Luciano A. Marraffini,et al.  Co-transcriptional DNA and RNA Cleavage during Type III CRISPR-Cas Immunity , 2015, Cell.

[36]  J. Doudna,et al.  A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.

[37]  S. Horinouchi,et al.  Nucleotide sequence and functional map of pE194, a plasmid that specifies inducible resistance to macrolide, lincosamide, and streptogramin type B antibodies , 1982, Journal of bacteriology.

[38]  S. Elena,et al.  Virus Satellites Drive Viral Evolution and Ecology , 2015, PLoS genetics.

[39]  Q. She,et al.  An archaeal CRISPR type III-B system exhibiting distinctive RNA targeting features and mediating dual RNA and DNA interference , 2014, Nucleic acids research.

[40]  R. Barrangou,et al.  CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes , 2007, Science.

[41]  S. Horinouchi,et al.  Nucleotide sequence and functional map of pC194, a plasmid that specifies inducible chloramphenicol resistance , 1982, Journal of bacteriology.

[42]  P. Horvath,et al.  Mobile CRISPR/Cas-Mediated Bacteriophage Resistance in Lactococcus lactis , 2012, PloS one.

[43]  K. Datsenko,et al.  Highly efficient primed spacer acquisition from targets destroyed by the Escherichia coli type I-E CRISPR-Cas interfering complex , 2016, Proceedings of the National Academy of Sciences.

[44]  Chad W. Euler,et al.  Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials , 2014, Nature Biotechnology.

[45]  L. Marraffini,et al.  Mature clustered, regularly interspaced, short palindromic repeats RNA (crRNA) length is measured by a ruler mechanism anchored at the precursor processing site , 2011, Proceedings of the National Academy of Sciences.

[46]  Sita J. Saunders,et al.  An updated evolutionary classification of CRISPR–Cas systems , 2015, Nature Reviews Microbiology.

[47]  Konstantin Severinov,et al.  Interference by clustered regularly interspaced short palindromic repeat (CRISPR) RNA is governed by a seed sequence , 2011, Proceedings of the National Academy of Sciences.

[48]  Xu Peng,et al.  A novel interference mechanism by a type IIIB CRISPR‐Cmr module in Sulfolobus , 2013, Molecular microbiology.

[49]  Luciano A. Marraffini,et al.  Cas9 specifies functional viral targets during CRISPR-Cas adaptation , 2015, Nature.

[50]  Joshua R. Elmore,et al.  DNA targeting by the type I-G and type I-A CRISPR–Cas systems of Pyrococcus furiosus , 2015, Nucleic acids research.